Filing Flows › Comparisons › CPIX vs LIFD
Cumberland Pharmaceuticals vs Lftd Partners: CPIX and LIFD compared
Cumberland Pharmaceuticals is the larger company: $8.8M of revenue in its latest quarter (Q2 2026) against $8.7M for Lftd Partners (Q2 2026). Lftd Partners is growing faster (-16% against -19% a year earlier). Lftd Partners is more profitable, with an operating margin of -17.5% against -35.9%.
Where the money goes: CPIX and LIFD
Cumberland Pharmaceuticals (CPIX) · Q2 2026
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Lftd Partners (LIFD) · Q2 2026
Lftd Partners, Q2 2026: revenue $8.7M (-16% year over year), operating margin -17.5%, net loss $1.4M, operating cash flow −$555K. The chart follows the revenue to costs, profit and cash.
| Cumberland Pharmaceuticals (CPIX) | Lftd Partners (LIFD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $8.8M | $8.7M |
| Revenue growth, Y/Y | -19% | -16% |
| Operating margin | -35.9% | -17.5% |
| Net earnings | −$4.3M | −$1.4M |
| Net margin | -48.6% | -16.5% |
| Operating cash flow | $169K | −$555K |
| Free cash flow | $130K | — |
Where the revenue comes from
Cumberland Pharmaceuticals
- Talicia: $2.3M (27%)
- Sancuso: $1.8M (21%)
- Vibativ: $1.7M (20%)
- Caldolor: $1.5M (17%)
Lftd Partners
- Products to Distributors: $6.1M (70%)
- Products to End Consumers: $1.2M (14%)
- Products to Wholesalers: $962K (11%)
- Products to Private Label Clients: $361K (4%)
Questions
Which is bigger, Cumberland Pharmaceuticals or Lftd Partners?
Cumberland Pharmaceuticals is the larger company: $8.8M of revenue in its latest quarter (Q2 2026) against $8.7M for Lftd Partners (Q2 2026).
Is Cumberland Pharmaceuticals or Lftd Partners growing faster?
Lftd Partners is growing faster (-16% against -19% a year earlier).
Which is more profitable, Cumberland Pharmaceuticals or Lftd Partners?
Lftd Partners is more profitable, with an operating margin of -17.5% against -35.9%.
More: Cumberland Pharmaceuticals earnings · how Cumberland Pharmaceuticals makes money · Lftd Partners earnings · how Lftd Partners makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 7, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.